Both in Pharmaceuticals
Harmony Biosciences Holdings vs Zenas BioPharma
Over the past year HRMY returned +12.0% and ZBIO returned −5.0%; their daily moves had a correlation of 0.17.
HRMY +12.0% ZBIO −5.0%Growth of $1, one year, split-adjusted
| Metric | HRMY | ZBIO |
|---|---|---|
| Price | $34.42 | $28.46 |
| Market cap | $2.00B | $1.85B |
| Today | −7.04% | +0.28% |
| 1 month | −12.6% | +5.6% |
| 6 months | +5.0% | +36.6% |
| Year to date | −8.0% | −21.6% |
| 1 year | +17.3% | −9.2% |
| Revenue growth (YoY) | +30.3% | — |
| Gross margin | 75.8% | 100.0% |
| Net margin | 28.9% | −11145.6% |
| P/E (TTM) | 11.1× | — |
| Price / sales | 2.1× | 1,854.9× |
| Net cash | $513.8M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 35.9% | 55.8% |
| Short % of float | 11.8% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).